v3.26.1
Stockholders’ Equity (Details) - DIAMIR BIOSCIENCES CORP. [Member] - USD ($)
9 Months Ended 12 Months Ended
Feb. 28, 2026
Feb. 28, 2025
May 31, 2026
May 31, 2025
May 31, 2024
May 31, 2023
Stockholders’ Equity [Line Items]            
Stock-based compensation expense   $ 20,418   $ 24,312 $ 194,846  
Unrecognized stock-based compensation expense related to options $ 0     0    
Unrecognised stock based compensation non vested 1,093,712     1,093,712    
Weighted average grant date fair value (in Dollars per share)     $ 652,080   $ 7  
Discount on note payable $ 12,694 $ 24,970   34,692 $ 35,063  
Number of shares issued for convertible debt (in Shares)         29,336  
Exercisable price (in Dollars per share) $ 1.8 $ 5.87        
Cash contribution $ 250,000 $ 200,000   $ 300,000 $ 200,000  
Debt conversion converted value         $ 5.87  
Shares issued for vested (in Shares)         246,000  
Outstanding stock options (in Shares)         140,000  
Restricted stock units (in Shares)           132,000
Terminated outstanding restricted stock shares (in Shares)       44,000    
Unrecognized stock-based compensation expense related to restricted stock units       $ 652,080    
Founder One [Member]            
Stockholders’ Equity [Line Items]            
Cash contribution       $ 250,000    
Shares issued (in Shares)       2,200,000    
Founder Two [Member]            
Stockholders’ Equity [Line Items]            
Shares issued (in Shares)       2,000,000    
Common Stock [Member]            
Stockholders’ Equity [Line Items]            
Number of shares issued for convertible debt (in Shares)   29,336        
2024 Stock Option Plan [Member]            
Stockholders’ Equity [Line Items]            
Options issuable (in Shares)       600,000    
Shares avaliable for grant increase percentage       2.00%    
Research and Development Expense [Member]            
Stockholders’ Equity [Line Items]            
Stock-based compensation expense $ 0       $ 182,912  
General and Administrative Expense [Member]            
Stockholders’ Equity [Line Items]            
Stock-based compensation expense         $ 11,934  
Maximum [Member]            
Stockholders’ Equity [Line Items]            
Stock options exercise price (in Dollars per share)         $ 7.01  
Minimum [Member]            
Stockholders’ Equity [Line Items]            
Stock options exercise price (in Dollars per share)         $ 0.01